Eric Mosbrooker - Aug 25, 2021 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Role
Director
Signature
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
Stock symbol
RNA
Transactions as of
Aug 25, 2021
Transactions value $
$0
Form type
4
Date filed
8/27/2021, 07:37 PM
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNA Stock Option (Right to Buy) Award $0 +30K $0.00 30K Aug 25, 2021 Common Stock 30K $20.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on August 25, 2021 and shall vest in substantially equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Registrant on each such vesting date.